Process Validation: A Lifecycle Approach — Oral Solid Dosage/ Semisolid Dosage Forms Annex - New Course
Registration Options
Individual Registration
Group Registration
Time: 8:30 a.m. - 4:00 p.m.
The participant will learn how to employ process understanding and quality risk management principles to the three Process Validation concepts described below:
- Stage 1: Process Design
- Stage 2: Process Qualification
- Stage 3: Continued (Ongoing) Process Verification (CPV)
In addition, the participant will learn how to apply Stage 3 CPV concepts to existing company/site legacy products.
Who Should Attend
Managers, directors and new or experienced professionals in process development, process validation, and quality assurance personnel will benefit in taking this course.
Event Location
Contact
Program Inquiries
Training Course Inquiries
Registration Customer Care
More information coming soon.
Day 1
Upon completion of this course, you will be able to:
- Describe the requirements for the development of of a new product using a Process Design Stage and apply the lessons learned to your workplace
- Explain the requirements for the development of a new product using a Process Qualification Stage and apply the lessons learned to your workplace
- Demonstrate the ability to respond to unexplained departures from established ranges with clear identification of impact including linkage to the firm’s quality systems
- Develop a Stage 3 Continuous Process Validation program for legacy products which includes linkage to the firm’s quality systems
Continuing Education for Pharmacists
PDA is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants may sign up to receive Continuing Pharmacy Education (CPE) credits. To do so, participants must sign in at the beginning of the program, submit the provided evaluation forms and mail the CPE credit request to the address stated on the form. Attendees must be present at the full event to receive Continuing Pharmacy Education credit, which will be awarded as follows:
PDA #540 | ACPE #0116-0000-18-012-L04-P | 0.6 CEUs
Type of Activity: Application
Continuing Education for Professional Engineers
New Jersey
PDA is an approved provider by the New Jersey State Board of Professional Engineers and Land Surveyors to offer courses to New Jersey Professional Engineers for Continuing Professional Competency (CPC) credit. Following the full participation in this course, participants will receive a Certificate of Accomplishment specifying the number of CPC credits that may be awarded. This certificate can be submitted as verification of completion to the Board for license renewal.
The credit value of this course is 6 CPC credits.
North Carolina
PDA is recognized by the North Carolina Board of Examiners for Engineers and Surveyors as an Approved Sponsor of Continuing Professional Competency (CPC) activities for Professional Engineers licensed by North Carolina. To receive a Certificate of Accomplishment specifying the number of Professional Development Hours (PDHs) that may be awarded, course participants must request the North Carolina Board of Examiners evaluation form from PDA staff. This form must be completed onsite at the conclusion of the course and returned to PDA staff.
The credit value of this course is 6 PDHs.
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationPLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
PDA Training and Research Institute
4350 East West HighwayBethesda, MD , United States
José L. Toro, PhD, Principal Consultant, Lachman Consultants
José L. Toro, Ph.D. is a Principal Consultant in the Compliance Practice at Lachman Consultants who has extensive R&D Quality, and Quality Operations experience in the pharmaceutical industry. Dr. Toro specializes in the transformation of Quality and Technical Services organizations including Quality Systems, global implementations, corporate auditing, technology transfer and plant operations. He has a broad knowledge of regulatory compliance and quality control. Dr. Toro is well versed in FDA, MHRA, IMB, ANVISA; Japan and Korean inspections. He is highly experienced in manufacturing technologies for most dosage forms (aseptic processing, complex prefilled syringes, extended-release solids, liquids, semi-solids) parenterals, medical devices, combination products, as well as bulk operations. Dr. Toro co-authored the PDA Technical Report (TR 60-2) on Solid and Semi-solid Process Validation.